Abstract
Data-driven solutions offer great promise for improving healthcare. However standard clinical neuroimaging data is subject to real-world imaging artefacts that can render the data unusable for computational research. T1 weighted structural MRI is used in research to obtain volumetric measurements from cortical and subcortical brain regions. However, clinical radiologists often prioritise T2 weighted or FLAIR scans for visual assessment. As such, T1 weighted scans are often acquired but may not be a priority. This can result in artefacts such as partial brain coverage being systematically present in memory clinic data.
Here we present a neuroimaging pipeline to ameliorate such situations by filling the missing regions with synthetic data. We validate on artificially cropped scans from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), showing that our pipeline largely removes the artefact, improving volumetric biomarker accuracy while also retaining statistical differences between diagnostic groups. We demonstrate utility by achieving diagnostic classification performance comparable to uncorrupted data. This is an important contribution towards moving research from the lab into the real world.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. NPO is a UKRI Future Leaders Fellow (MR/S03546X/1) and acknowledges funding from the UKRI Medical Research Council for the project Piloting A Secure Scalable Infrastructure for AI in the NHS (PASSIAN: MR/X005674/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes